Onconova Therapeutics Inc

NASDAQ:ONTX   12:58:50 PM EDT
3.17
-0.12 (-3.65%)
Earnings Announcements

Onconova Therapeutics Reports Third Quarter 2021 Financial Results And Provides Business Update

Published: 11/11/2021 22:07 GMT
Onconova Therapeutics Inc (ONTX) - Onconova Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $0.22.
Onconova Therapeutics - Believes Cash, Cash Equivalents Will Be Sufficient to Fund Ongoing Clinical Trials & Business Operations for More Than 2 Yrs.
Revenue is expected to be $0.06 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0.1 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.